Abstract
Introduction
Osteoarthritis (OA) is a heterogeneous group of degenerative joint disease of multi-factorial origin, characterised by defective integrity and progressive loss of articular cartilage, subchondral bone remodelling, joint space narrowing and bone spur formation, as well as synovial inflammation 1 . Pain and functional impairment are the key domains of the burden of suffering experienced by people with OA that is of primary concern, and that burden can be significant, and taken together they often exert a significant reduction in quality of life 2, 3 . Since the last decade, recommendations for managing OA have focused persistently on relieving pain and stiffness and improving physical function as important goals of therapy 4, 5 . However, conventional drug therapy for OA successfully relieves pain only, alongside producing adverse gastrointestinal and cardiovascular effects, especially with long-term use 6 . Rheumatologic problems are among the most common disease conditions encountered by CAM practitioners 7, 8 . Many patients use CAM therapies including homoeopathy to prevent, control and manage the pain of rheumatologic conditions 9, 10 . However, scientific research has so far not provided evidences solid enough to support the effectiveness of CAM as treatment options for rheumatologic conditions including OA and has remained ambiguous 11 .
Reviews have remained contradictory in conclusions [12] [13] [14] [15] [16] [17] [18] . Few low-potency homoeopathic complexes in the randomised controlled trials seemed to posses significant effects in OA
19
, but the potential of individualised homoeopathy remained untested. Hence, based on small-to-moderate effect sizes for the wide range of symptomatic treatments, conventional medicine in individualised approach still remains the mainstay of treatment 20, 21 . The aim of this systemic review was to identify, evaluate and summarise the findings of all relevant individual studies, thereby making the available evidence more accessible to decision makers.
Materials and Methods

Protocol and registration
A specific protocol (03/2013-14/ CRU(H)/Slg/MTA/SS; version 1.1, 1 June 2013) was developed for conducting this systematic review. The protocol was registered vide CRD42013004970, 1 July 2013 with the PROSPERO International prospective register of systematic reviews, Centre for Reviews and Dissemination, the University of York, National Institute of Health Research, York, UK. PRISMA guidelines 22 were followed in structuring this review. 
Eligibility criteria
Summary measures
Descriptive summary was deduced from each study using the standardised data extraction form focusing on population recruited, interventions and comparator used, outcome measures, methods adopted, methodological scorings and overall result.
Results
Study selection and characteristics
From 1980 till 2013, a total of eight peer-reviewed published papers [25] [26] [27] [28] [29] [30] [31] [32] on clinical trials on homoeopathic treatment of OA were identified to be eligible (Figure 1) . None of these trials tested individualised homoeopathy, rather used 'complexes' and 'combination formulae' versus either placebo control or adopted pragmatic study designs. Besides, we could identify also one prospective multi-centric open observational clinical study using individualised
Study selection
Only prospective controlled clinical trials with clearly defined predetermined outcomes and published research journal literature in English were included.
Data collection process
A standardised data extraction form was designed by the reviewers and pilot tested on three studies to provide consistency in the review, whilst reducing bias and improving validity and reliability. For each trial, main characteristics and results were extracted independently by two reviewers.
Data items
Data were extracted on the following grounds: patients (number included/analysed, condition treated, demographics, setting), intervention and comparator (homoeopathic intervention, comparator/control), outcomes (overall assessment, patients assessed globally as improved), study design (allocation to group, blinding, concealment of allocation, selection bias after allocation, duration of observation), two scoring conventional therapies and a complete, accessible, research journal paper was available in English (paper in German was also considered eligible if a translated reprint in English was available) and published between 1980 and 2013. Eligibility was assessed by the reviewers.
Search strategy
Different electronic bibliographic databases like MEDLINE (via PubMed), Cochrane, Google Scholar, EMBASE (Elsevier), AMED (British Library), CCRH (India), CINAHL (EBSCO Publishing, Ovid Technologies, ProQuest), CISCOM (RCCM, London), CAM (University of Maryland, School of Medicine), HomInform (Glasgow Homeopathic Hospital), LILACS (Virtual Health Library, Brasil), MANTIS (ChiroAccess) and SIGLE (Europe) were searched for relevant literature. Search terms used were 'osteoarthritis', 'osteoarthrosis', 'gonarthrosis', 'homeopathy', 'homoeopathy', 'alternative medicine' and 'complementary medicine'. Data were also obtained by contact with individual researchers. We also searched comprehensively electronic databases to identify any reviews conducted in the relevant field, namely MEDLINE (via PubMed), Database of Abstracts of Reviews of Effects (DARE), Cochrane Database of Systematic Reviews (CDSR), Campbell Library of Systematic Reviews (CLSR), National Institute for Health and Clinical Excellence (NICE), NIHR Health Technology Assessment (NIHR HTA), Evidence for Policy and Practice Information (EPPI), Database of systematic and non-systematic reviews of Public Health interventions (DoPHER), National Guidelines Clearinghouse (NGC) and Scottish Intercollegiate Guidelines Network (SIGN). We visually scanned reference lists from relevant studies; hand searched key journals and trial registers; contacted study authors, experts, manufacturers and other organisations and conducted citation searching. Titles, abstracts and full texts identified and screened; n = 30 Excluded; n = 1 Reason: Unable to obtain further information required to make assessment Full copies retrieved and assessed for eligibility; n = 29 Excluded; n = 21 Reasons:
Design not relevant (observational study); n = 1 Reprint publication; n = 1 Translated publications; n = 2 Reviews; n = 13 No clear comparison group; n = 2 OA as outcome not specified; n = 2
Publications meeting inclusion criteria; n = 8
Publications included in the review; n = 8 this approach may provide a way to combine results from very dissimilar trials with differing outcomes and statistical tests.
Reviews that include only published studies like ours might be at risk of overestimating the treatment effect. Including data from unpublished studies (or unpublished outcomes) is therefore important in minimising bias. However, this can be time-consuming, and the original data may no longer be available. Although those performing individual patient data meta-analyses have generally been successful in obtaining data from the authors of unpublished studies, the same may not be true of other types of reviews. The practical difficulties of locating and obtaining information from unpublished studies may, for example, make the ideal of including relevant unpublished studies unachievable in the timescales available for many commissioned reviews. When information from unpublished studies is obtained, the published and unpublished material should be subjected to the same methodological evaluation.
This study is restricted by chances of potential flaw or premature negative bias of making any conclusion from the limited quantity of trials currently available in peer-reviewed literature, especially in the context of absence of any single trial testing individualised homoeopathy, the 'classical' form of homoeopathy. However, the obvious advantage of not using individualised homoeopathy was the absence of some inherent debatable issues like 'empathy' or 'consultation biases', and ambiguity regarding selection of the correct individualised medicine for a given condition. Inadequate reporting has also inadvertently introduced a source of error into the trials. While the standard practice is to report the 95% confidence limits and twotailed P-values, these were missing in many studies. of homoeopathy 34 ; but our analysis generated conflicting evidence. Studies with the highest methodological qualities, that is, those done by van Haselen et al. and Widrig et al., produced significantly positive results, suggesting an advantage of using homoeopathic therapy over conventional therapies. Finally, it can be concluded that evidences have been generated to support the use of 'complex homoeopathy' over placebo and almost in equivalence to conventional therapies for managing OA.
Strengths and limitations
As we identified varying trials in terms of using homoeopathic (not truly 'homoeopathic') treatment in a single disease (OA) using different end-points (both dichotomous and continuous) like global improvement in the number of patients in either group, reduction in visual analogue scales measuring pain on movement and during rest, stiffness and loss of function, WOMAC indices of OA etc., the assumption of a common underlying treatment effect size seems to be inappropriate. Thus, heterogeneity existed in terms of using differing outcome measures, differing intervention and comparators (either placebo or conventional therapies; differing in dosage, duration, mode of intervention), differing study design (randomised/non-randomised/ quasi-randomised; open/single blind/double blind etc.) and differing statistical tests applied. Therefore, a combination of significance levels (sum of logs, sum of Z, weighted sum of Z, sum of t, mean Z, mean P, count test and logit procedure) may be been chosen as a more appropriate statistical approach to perform a meta-analysis. An overview of the patients, methods, interventions and results of the 10 included trials is given in Table 1 .
Results of individual studies
The highest methodological scoring, both as per Jadad scale and bias minimisation, was obtained conjointly by the studies by van Haselen et al. 28 and Widrig et al. 31 . The studies by Birnesser et al. 30 and Strösser et al. 32 were of the poorest methodological qualities. None tried individualised homoeopathy; instead various 'complexes' and 'combination formulae' against placebo, conventional oral drugs, topical gels or intra-articular injections are used. The studies recruited a total of 1,444 patients, and six of those studied OA knee, one studied both OA knee and hip and one studied OA hand. Randomisation was used in seven of the eight studies (one study not mentioning and describing randomisation properly 27 ) and double blinding by six studies. One study was single blind 26 and one was open label 30 . Only a single study used cross-over design 25 . The study by Birnesser et al. 30 was a prospective cohort study. Study duration ranged between 3 and 10 weeks (Table 1) .
Discussion
Summary of evidence A total of eight clinical trials on OA were included in our systematic review. Individualised ('classical') homoeopathy has not been tested in any of the trials identified. Another clear shortcoming is that extraction and assessments were made by the reviewers manually. Disagreements were resolved by discussion with involvement of a third reviewer as and when necessary. Instead, the quality assessments and the results of this qualitative systematic review should be interpreted with caution. The methodological assessment, though explicit, involved subjective judgements. These quality scoring methods are useful in evaluating the robustness of results of a review when corrected for possible sources of bias. However, for a more in-depth assessment, these scores are too crude, too formal and depend too much on reporting. To date, and given the often insufficient detail in reporting, a valid and reliable assessment of methodological quality remains elusive. In particular, the reliability of data collection can hardly be assessed unless it is guaranteed that good clinical practice (GCP) guidelines have been followed. With these shortcomings in mind, the results of this qualitative analysis should only be seen as a crude indicator of the trend of the results in the single trials.
Conclusion
In spite of the insufficient quantity of research literature and insufficient trial reporting, this review concludes that there is clear evidence that homoeopathic complexes and combination formulae play a considerable role in treatment of OA; however, immediate uptake of trials testing individualised homoeopathy followed by further confirmatory independent replications is warranted, provided the trials are rigorous and systematic.
